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1. Introduction 
Interferons are cell-derived glycoproteins induced 
by viral infection and by a variety of non-viral agents. 
They are characterized principally by their capacity 
to establish an antiviral resistance in sensitive cells 
PI. 
Recent reports from several aboratories [2-41 
have shown that the translation of messenger RNAs, 
from viral and cellular origin, was impaired in cell- 
free systems derived from interferon treated cells. The 
synthesis of total cellular proteins, measured either in 
whole cells or in cell-free systems, was inhibited by 
the interferon treatment, but to a lesser extent [5]. 
In the present work, the effect of interferon on the 
synthesis of a specific enzymic protein has been stud- 
ied in vivo. We utilised the particularity of the outstand- 
ing property of hepatoma tissue culture (HTC) cells 
which respond to adrenal steroids by a 5-15-fold 
increase of the synthesis of tyrosine aminotransferase 
(TAT) [6]. Our results show that partially purified 
mouse interferon, which has antiviral activity in rat 
cells, and crude rat interferon act on HTC cells by an 
inhibition of steroid-induced TAT. 
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2. Materials and methads 
2.1. Interferon preparations and assays 
Rat tibroblast interferon (RF-I) was prepared on 
2-3 days old confluent monolayers of primary rat 
embryo cells (PREC) infected with Newcastle disease 
virus (NDV, Hertz strain). After 24 hr incubation at 
37’C the culture fluids were harvested, the remaining 
virus inactivated by pH 2 treatment for 5 days, and 
ultracentrifuged. The preparations were then con- 
centrated 5 to 10 times by pressure dialysis. Rat 
serum interferon (RS-I) was produced in rats by 
intravenous injection of 1 ml NDV suspension (about 
5 X 10’ EID 50). Interferon appeared in the sera with 
a peak at 6 to 8 hr after inoculation. The viral inducer 
was inactivated as described above. Both interferons 
were titrated by the plaque reduction test on PREC 
cells using Vesicular stomatitis virus (VSV) as challenge 
virus. RF-I had a titer of 250-500 units/ml. The titer 
of RS-I was 500 units/ml. 
Mouse L cell interferon (ML-I) was prepared and 
purified as previously described [2]. Its final specific 
activity ranged from 5 X lo6 to 10’ international 
units/mg protein when the assay was performed on 
L cells. This interferon also showed an antiviral effect 
when tested on cells of related species [7] . In our 
hands, the ML-I exerted about 2% of its homologous 
activity. In the experiments detailed here, all the inter- 
feron titers are expressed in rat units. 
2.2. Cell cultures, protein and TAT determinations 
HTC cells were grown at 37°C in suspension cul- 
tures in Swim’s 77 medium supplemented with 10% 
calf serum [8] . Cell counting was performed in the 
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presence of Trypan Blue for evaluation of viability. 
TAT enzymic activity was assayed by the method 
of Diamondstone [9]. Protein concentration was 
determined by the method of Lowry et al. [lo]. 
3. Results 
All experiments were performed on HTC cells in 
suspension cultures. The various preparations of inter- 
feron were added 15 hr prior to the addition of 
10e7 M dexamethasone as inducer of TAT synthesis. 
Samples were taken 4, 10, 16 and 24 hr after addition 
of the hormonal inducer in order to estimate the cell 
concentration, the total protein concentration and 
the enzymic activity of TAT. Fig. 1 shows that the 
treatment with interferon produced a decrease in the 
specific activity of TAT, which was dose dependent. 
Two consecutive aspects of interferon action can be 
pointed out: (i) during the first 10 hr following the 
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Fig. 1. Time course of the inhibition of steroid induced TAT in HTC cells by interferon of different origins. HTC cells were grown 
in batches of 30 ml suspension cultures at a concentration of 3 X 10e5 cells/ml. 3 ml of PBS (control), mock interferon diluted 
in PBS or interferon diluted in PBS in the concentration indicated below was added. 15 hr later, HTC cells were induced to 
synthesize tyrosine aminotransferase by adding lo-’ M dexamethasone. TAT specific activity (units/mg protein) was determined 
for various induction times: control (=-g-m), cells pretreated with mock interferon (A-A-A), mouse interferon, ML-I, 300 units/ 
ml (o--..), rat fibroblast interferon, RF-I, 3 units/ml (z--z), rat serum interferon, RS-I, 3 units/ml (b-.-_) and 15 units/ml (o......o). 
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addition of the hormone, TAT induction was 
partially inhibited; after this period, the maximum 
level of enzymic activity was reached in the control 
as well as in the interferon treated cells; the decrease 
of specific activity relative to control cells ranged 
from 14 to 34%, depending on the dose of interferon; 
(ii) after reaching the maximum level of induction, 
the specific activity of the enzyme decreased in the 
interferon treated cultures although it remained un- 
changed in the control cultures for the next 14 hr. At 
that time the decrease of specific activity reached 33 
to 54%, and was also dose dependent. 
In addition to this specific effect, we confirmed 
(table 1) the previously reported action of interferon 
on cell division associated with a decrease in the total 
protein synthesis [ 111. For instance, with the highest 
dose of interferon tested (300 units/ml), no cell 
division could be observed. Nevertheless the interferon 
added did not display any toxic effect, as no dead cells 
could be observed in the medium. 
4. Discussion 
Our results confirm the inhibitory effect of inter- 
feron on the translation of cellular messenger RNAs 
[S] ; the present.demonstration concerns the in vivo 
synthesis of a hormone-inducible specific protein. 
The experiments reported here were performed 
with crude preparations of two different kinds of rat 
interferon and with a partially purified mouse inter- 
feron. Even if we cannot exclude the possibility that 
the inhibition we describe is related to the presence of 
impurities, it is nevertheless unlikely that all the pre- 
parations, which differ in origin, should all contain the 
same active impurity. Moreover the inhibition is dose 
dependent and the doses have been measured as a 
function of the antiviral action. 
Recently, Vassef et al. [ 121 reported, with tech- 
niques somewhat different from ours, a 20% inhibition 
of TAT induction in layer cultures of HTC cells 
pretreated with an interferon prepared on the same 
cells with poly I:poly C as inducer. Our results include 
the kinetic study of the induction of TAT synthesis, 
in the presence or absence of interferon. 
In fact, interferon not only inhibits the synthesis 
of this specific enzymic protein, but also acts on the 
total cellular proteins. However TAT is more affected 
than the overall protein synthesis. Thus, it seems that 
the proteins which are synthesized at a faster rate are 
more inhibited by the interferon action. 
The steady state reached in control cultures is the 
Table 1 
The effects of interferon pretreatment on cell growth and protein 
content during TAT induction 
Hormone induction time 
0 24 hr 
Interferon treatment Cell number Protein Cell number Protein 
x lo5 pgg/ml x 10s fig/ml 
Control (no addition) 4.22 246 6.56 360 
Mock interferon 4.32 243 6.70 365 
Rat serum interferon 
3 units/ml 3.99 236 4.56 279 
5 units/ml 3.28 226 3.98 242 
Rat fibroblast 
interferon 3 units/ml 3.96 220 4.38 281 
Mouse interferon 
300 units/ml 3.04 158 2.98 168 
HTC cells were grown and treated as described in fig. 1. 
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consequence of an equilibrium between the synthesis 
and the ‘normal’ degradation of the enzyme [ 131. In 
the interferon-treated cultures the decrease of the 
specific activity of the enzyme presents some similari- 
ties with the decrease observed upon removal of the 
inducer, or with the ‘enhanced’ degradation of TAT 
in HTC cells grown in ‘step-down’ conditions [8]. 
The molecular basis of the decrease of the specific 
activity of the enzyme in interferon treated cells 
remains to be established. 
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